UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Claro Advisors LLC

Claro Advisors LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 8,345 shares of the healthcare conglomerate’s stock after selling 1,287 shares during the quarter. Claro Advisors LLC’s holdings in UnitedHealth Group were worth $4,221,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $27,000. Global Wealth Strategies & Associates lifted its holdings in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares during the period. West Financial Advisors LLC acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $32,000. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $37,000. Finally, Quarry LP increased its stake in shares of UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 4.0 %

UNH opened at $541.28 on Tuesday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The stock has a market capitalization of $498.13 billion, a PE ratio of 35.26, a P/E/G ratio of 1.53 and a beta of 0.62. The business’s 50 day moving average price is $554.92 and its 200 day moving average price is $562.88. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the prior year, the firm posted $6.56 earnings per share. The firm’s quarterly revenue was up 9.2% on a year-over-year basis. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

Analyst Ratings Changes

Several equities analysts recently weighed in on UNH shares. TD Cowen lifted their price target on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Cantor Fitzgerald lifted their price target on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. Piper Sandler cut their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Monday, December 9th. Finally, HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research note on Friday. Two analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $626.79.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.